Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Healthcare
/
OPKO Health
OPK
OPKO Health
Regulations And Competition Will Strain Diagnostics But Hope Will Prevail
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 6 Analysts
Published
08 Aug 25
Updated
16 Aug 25
0
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
US$2.00
30.5% undervalued
intrinsic discount
16 Aug
US$1.39
1Y
-14.2%
7D
-0.7%
Loading
1Y
-14.2%
7D
-0.7%
Author's Valuation
US$2.0
30.5% undervalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
US$2.0
30.5% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-303m
2b
2014
2017
2020
2023
2025
2026
2028
Revenue US$658.2m
Earnings US$34.7m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
5.66%
Healthcare Services revenue growth rate
0.26%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
6.78%
Calculation
US$34.70m
Earnings '28
x
68.19x
PE Ratio '28
=
US$2.37b
Market Cap '28
US$2.37b
Market Cap '28
/
972.42m
No. shares '28
=
US$2.43
Share Price '28
US$2.43
Share Price '28
Discounted to 2025 @ 6.78% p.a.
=
US$2.00
Fair Value '25
